Wellbeing Digital Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KONEF research report →
About the company
With its origins as KetamineOne Capital Limited, this innovative wellness organization is dedicated to advancing ketamine-assisted therapy and psychedelic medicines. It achieves this mission by managing a network of healthcare clinics across North America. The company, which commenced operations in 2017 and is headquartered in Vancouver, Canada, was formerly recognized as Myconic Capital Corp.
- CEO
- Najla Guthrie
- IPO
- 2021
- Employees
- 3
- HQ
- Vancouver, BC, CA
Price Chart
- Revenue
- $6.44M · 469.43%
- Net Income
- $-25,205,741 · 21.02%
- EPS
- $-0.21 · 43.24%
- Op Income
- $-23,781,028
- FCF YoY
- 99.84%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -7.38
- Avg Volume
- 235.52
Get TickerSpark's AI analysis on KONEF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our KONEF coverage
Recent articles, reports, and earnings notes.
No research on KONEF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KONEF report →Similar companies
Peers in the same neighborhood.